MSB 1.01% 98.0¢ mesoblast limited

Till FDA stamp approval for remestemcel-L, celebration is too...

  1. 424 Posts.
    lightbulb Created with Sketch. 30
    Till FDA stamp approval for remestemcel-L, celebration is too early.
    From my points view, high possibility,90%?

    Then another milestone is earlier Sep/2020, COVID-19 readout for 90 patients.

    For long holder, just waiting solid news coming.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
-0.010(1.01%)
Mkt cap ! $1.118B
Open High Low Value Volume
$1.00 $1.01 98.0¢ $4.720M 4.751M

Buyers (Bids)

No. Vol. Price($)
10 171759 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 16000 1
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.